Format

Send to

Choose Destination
See comment in PubMed Commons below
Radiother Oncol. 2008 Feb;86(2):165-70. doi: 10.1016/j.radonc.2007.12.003. Epub 2008 Jan 14.

Secondary neutrons in clinical proton radiotherapy: a charged issue.

Author information

1
Center for Radiological Research, Columbia University Medical Center, NY 10032, USA. djb3@columbia.edu

Abstract

Hospital-based proton facilities may represent a major advance in radiation therapy, in part because of excellent dose distributions around the tumor, and in part because of the potentially lower whole-body dose compared with photon radiotherapy. Most current proton beams are spread out to cover the tumor using beam scattering and collimation techniques (passive scattering); this will necessarily result in an extra whole-body neutron dose, due to interactions of the protons with the scattering and collimating beam elements. However, the clinical significance of this whole-body low-dose neutron exposure has remained controversial. The number of proton facilities worldwide is increasing rapidly, and most of these facilities are/will be based on passive scattering. Thus it is important to assess and, ideally, minimize, the potential for second cancer induction by secondary neutrons. We discuss here the neutron doses involved, and the associated potential second cancer risks, with an emphasis on the uncertainties involved.

PMID:
18192046
DOI:
10.1016/j.radonc.2007.12.003
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center